论文部分内容阅读
目的:探究应用地塞米松短期冲击滴眼联合盐酸奥洛他定维持滴眼治疗慢性过敏性结膜炎的临床效果。方法:随机抽取2011年-2013年仙桃市杨林尾镇卫生院收治的慢性过敏性结膜炎患者50例并将其分为对照组与观察组,每组均有患者25例(50眼)。对照组单纯应用盐酸奥洛他定维持滴眼治疗方案,观察组则是在对照组治疗基础上联合地塞米松短期冲击滴眼,比较两组患者临床治疗效果。结果:观察组临床总有效率为92.0%(46眼),对照组临床总有效率为64.0%(32眼),两组比较,差异有统计学意义(P<0.05)。结论:地塞米松短期冲击滴眼联合盐酸奥洛他定维持滴眼治疗方案对慢性过敏性结膜炎疗效较好,能够在短时间内改善患者眼部症状以及体征。
Objective: To investigate the clinical effect of dexamethasone short-term impact eye drops combined with olopatadine hydrochloride in the treatment of chronic allergic conjunctivitis. Methods: A total of 50 patients with chronic allergic conjunctivitis who were admitted to Yanglinwei Township Health Center in Xiantao City from 2011 to 2013 were randomly selected and divided into control group and observation group. Each group had 25 patients (50 eyes). The control group was treated with olopatadine hydrochloride alone. The observation group was treated with the short-term impact of dexamethasone on the basis of the control group, and the clinical effects of the two groups were compared. Results: The total clinical effective rate was 92.0% (46 eyes) in observation group and 64.0% (32 eyes) in control group. The difference between the two groups was statistically significant (P <0.05). Conclusion: The short-term impact of dexamethasone eye drops combined with olopatadine hydrochloride eye drops treatment programs for chronic allergic conjunctivitis better effect, in a short time to improve the patient’s eye symptoms and signs.